UDICARE 450

MRP

MRP 490/Strip

Description

• Each film coated tablet contains Ursodeoxycholic Acid IP 450 mg (in sustained release form)

Doses

As Directed by physician

Indication

• Ursodeoxycholic acid is indicated in the treatment of primary biliary cirrhosis (PBC) and for the dissolution of radiolucent gallstones in patients with a functioning gall bladder. Hepatobiliary disorders associated with cystic fibrosis in children aged 6 to 18 years